tiprankstipranks
Spero Therapeutics reports Q1 EPS (24c), consensus (4c)
PremiumThe FlySpero Therapeutics reports Q1 EPS (24c), consensus (4c)
2M ago
Spero Therapeutics to Report First Quarter 2024 Financial Results and Provide Business Update on Wednesday, May 15, 2024
PremiumPress Releases
Spero Therapeutics to Report First Quarter 2024 Financial Results and Provide Business Update on Wednesday, May 15, 2024
3M ago
Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PremiumPress Releases
Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
3M ago
Spero Therapeutics to Provide Business Update and Report Fourth Quarter and Full Year 2023 Financial Results on Wednesday, March 13, 2024
PremiumPress ReleasesSpero Therapeutics to Provide Business Update and Report Fourth Quarter and Full Year 2023 Financial Results on Wednesday, March 13, 2024
5M ago
Cantor Fitzgerald biotech/biopharma analysts analyst/industry conference call
PremiumThe Fly
Cantor Fitzgerald biotech/biopharma analysts analyst/industry conference call
5M ago
Cantor Fitzgerald biotech/biopharma analysts analyst/industry conference call
PremiumThe Fly
Cantor Fitzgerald biotech/biopharma analysts analyst/industry conference call
5M ago
Spero Therapeutics Announces Chief Legal Officer’s Resignation
PremiumCompany AnnouncementsSpero Therapeutics Announces Chief Legal Officer’s Resignation
5M ago
Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PremiumPress Releases
Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
6M ago
Spero Therapeutics expects cash to fund requirements into late 2025
PremiumThe Fly
Spero Therapeutics expects cash to fund requirements into late 2025
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100